COMMERZBANK AKTIENGESELLSCHAFT /FI - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.

Quarter-by-quarter ownership
COMMERZBANK AKTIENGESELLSCHAFT /FI ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2019$629,000
-37.7%
6,640
-42.9%
0.01%
-12.5%
Q3 2019$1,010,000
-4.8%
11,6210.0%0.01%
+14.3%
Q2 2019$1,061,000
+57.9%
11,621
+66.3%
0.01%0.0%
Q1 2019$672,000
-78.5%
6,990
-80.8%
0.01%
-79.4%
Q4 2018$3,119,000
-10.9%
36,352
-10.5%
0.03%
+3.0%
Q3 2018$3,500,000
-4.3%
40,618
-16.1%
0.03%
-10.8%
Q2 2018$3,658,000
+6.2%
48,425
+13.7%
0.04%
-2.6%
Q1 2018$3,444,000
+1.7%
42,602
+5.6%
0.04%
-9.5%
Q4 2017$3,387,000
-13.4%
40,336
-11.5%
0.04%
-19.2%
Q3 2017$3,911,000
+45.4%
45,562
+41.4%
0.05%
+15.6%
Q2 2017$2,690,000
+4.1%
32,227
-7.3%
0.04%
+18.4%
Q1 2017$2,583,000
+16.6%
34,778
+14.3%
0.04%
+15.2%
Q4 2016$2,216,000
-5.7%
30,416
+2.2%
0.03%
-13.2%
Q3 2016$2,350,000
-7.7%
29,767
-3.6%
0.04%
+123.5%
Q2 2016$2,547,000
-1.8%
30,863
-13.8%
0.02%
-22.7%
Q1 2016$2,595,000
-11.0%
35,819
+5.7%
0.02%0.0%
Q4 2015$2,916,000
-5.7%
33,887
+0.8%
0.02%
-4.3%
Q3 2015$3,091,000
+12.3%
33,630
+20.2%
0.02%
+64.3%
Q2 2015$2,753,000
-0.3%
27,9900.0%0.01%
-17.6%
Q1 2015$2,760,000
+19.2%
27,990
+12.0%
0.02%
+13.3%
Q4 2014$2,316,000
-1.6%
25,0000.0%0.02%
+66.7%
Q3 2014$2,353,00025,0000.01%
Other shareholders
NOVARTIS A G shareholders Q3 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders